| Valuation method | Value, ¥ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 502.72 | -55 |
| Intrinsic value (DCF) | 341.07 | -69 |
| Graham-Dodd Method | 235.86 | -79 |
| Graham Formula | 119.46 | -89 |
CE Holdings Co., Ltd. (4320.T) is a Japan-based company specializing in the development and sale of electronic medical record (EMR) systems and medical information systems. Operating primarily in Japan, the company's flagship product, MI RA Is (Miraize), is a comprehensive EMR solution designed for medical institutions, streamlining patient data management and improving healthcare efficiency. Formerly known as CEI Corporation, the company rebranded to CE Holdings Co., Ltd. in 2013. Headquartered in Sapporo, CE Holdings has been a key player in Japan's healthcare IT sector since its inception in 1996. The company serves a critical role in digitizing medical records, aligning with Japan's push for advanced healthcare technology. With a market capitalization of approximately ¥10.3 billion, CE Holdings operates in the Medical - Healthcare Information Services industry, contributing to the broader healthcare sector's digital transformation.
CE Holdings Co., Ltd. presents a niche investment opportunity in Japan's healthcare IT sector, with a focus on electronic medical record systems. The company's stable revenue (¥14.55 billion in FY 2024) and modest net income (¥123.4 million) reflect its established position in the market. However, investors should note the company's low beta (0.464), indicating lower volatility but also potentially limited growth momentum. The dividend yield, with a dividend per share of ¥18, may appeal to income-focused investors. Key risks include intense competition in the EMR space and reliance on the Japanese market. The company's strong cash position (¥3.83 billion) and manageable debt (¥2.16 billion) provide financial stability, but growth prospects may depend on expansion beyond its current offerings.
CE Holdings Co., Ltd. competes in Japan's electronic medical record (EMR) and healthcare IT market, where differentiation is often driven by system integration, user-friendliness, and compliance with local regulations. The company's competitive advantage lies in its specialized Miraize EMR system, tailored for Japanese medical institutions. However, its market share is challenged by larger domestic and international players with broader product portfolios and greater R&D resources. CE Holdings' focus on Japan limits its exposure to global markets, unlike some competitors who operate internationally. The company's financials suggest moderate profitability, with room for improvement in scaling operations. Its low beta indicates resilience to market fluctuations but may also reflect slower growth compared to more aggressive competitors. The healthcare IT sector in Japan is highly regulated, which benefits incumbents like CE Holdings but also creates barriers to rapid innovation. The company's ability to enhance its Miraize platform and expand its customer base will be critical in maintaining competitiveness against larger rivals.